Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer. The company also offers drug substances, general medicines, health functional foods, and nutrition and health products and services. In addition, it operates an online pharmacy; and offers pharmaceutical management automation systems. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is based in Seoul, South Korea.
Earnings for Hanmi Science Co., Ltd. (008930.KS)
Earnings in 2023 (TTM): $45.72 M
According to Hanmi Science Co., Ltd.'s latest financial reports the company's current earnings (TTM) are $45.72 M. The earnings displayed on this page is the company's Pretax Income.
Earnings history of Hanmi Science Co., Ltd.
Annual Earnings
| Year | Income Before Tax | Net Income |
|---|---|---|
| 2023 | $45.72 M | $83.44 M |
| 2022 | $53.04 M | $50.16 M |
| 2021 | $35.6 M | $31.12 M |
| 2020 | $21.72 M | $16.38 M |
| 2019 | $25.68 M | $22.28 M |
| 2018 | $13.64 M | $13.06 M |
| 2017 | $24.21 M | $21.79 M |
| 2016 | $13.71 M | $5.75 M |
| 2015 | $169.41 M | $129.39 M |
| 2014 | $13.53 M | $15.45 M |
| 2013 | $7.57 M | $6.94 M |
| 2012 | $9.32 M | $9.04 M |
| 2011 | $2.85 M | $-10,647,634 |
| 2010 | $-4,680,490 | $4.33 M |
| 2009 | $45.24 M | $36.62 M |
| 2008 | $68.06 M | $51.86 M |
| 2007 | $57.39 M | $38.41 M |